Jane Street Group, LLC Fibrogen Inc Transaction History

Jane Street Group, LLC

$444 Billion
Q4 2024

A detailed history of Jane Street Group, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 19,646 shares of FGEN stock, worth $5,893. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,646

Previous 58,418 66.37%

Holding current value

$5,893

Previous $23,000 56.52%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.3 - $0.58 $11,631 - $22,487	-38,772 Reduced 66.37%	19,646 $10,000
Q3 2024 Nov 14, 2024	SELL	$0.33 - $1.26 $129,206 - $493,335	-391,536 Reduced 87.02%	58,418 $23,000
Q2 2024 Aug 14, 2024	BUY	$0.89 - $2.36 $32,120 - $85,172	36,090 Added 8.72%	449,954 $400,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $27,438 - $102,612	37,587 Added 9.99%	413,864 $972,000
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $193,880 - $464,292	-510,212 Reduced 57.55%	376,277 $334,000
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $969,084 - $3.47 Million	-1,226,689 Reduced 58.05%	886,489 $762,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $4.13 Million - $34.2 Million	1,659,151 Added 365.43%	2,113,178 $5.71 Million
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $142,561 - $225,058	8,938 Added 2.01%	454,027 $8.47 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $719,711 - $961,604	54,236 Added 13.88%	445,089 $7.13 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $273,258 - $349,962	-23,970 Reduced 5.78%	390,853 $5.09 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $273,258 - $349,962	-23,970 Reduced 5.78%	390,853 $5.09 Million
Q2 2022 Aug 16, 2022	BUY	$7.94 - $12.96 $2.71 Million - $4.42 Million	341,150 Added 463.06%	414,823 $4.38 Million
Q4 2021 Feb 15, 2022	BUY	$9.93 - $15.39 $225,391 - $349,322	22,698 Added 44.53%	73,673 $1.04 Million
Q3 2021 Nov 16, 2021	SELL	$10.18 - $26.64 $995,288 - $2.6 Million	-97,769 Reduced 65.73%	50,975 $521,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $2.41 Million - $4.64 Million	129,976 Added 692.54%	148,744 $3.96 Million
Q1 2021 May 18, 2021	SELL	$31.0 - $55.72 $836,783 - $1.5 Million	-26,993 Reduced 58.99%	18,768 $651,000
Q4 2020 Feb 17, 2021	BUY	$37.09 - $48.97 $335,553 - $443,031	9,047 Added 24.64%	45,761 $1.7 Million
Q3 2020 Nov 17, 2020	SELL	$40.47 - $45.5 $45,731 - $51,415	-1,130 Reduced 2.99%	36,714 $1.51 Million
Q2 2020 Aug 17, 2020	BUY	$32.57 - $42.83 $1.04 Million - $1.37 Million	32,049 Added 553.05%	37,844 $1.53 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $1.41 Million - $2.78 Million	-60,414 Reduced 91.25%	5,795 $201,000
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $1.76 Million - $2.45 Million	51,008 Added 335.56%	66,209 $2.84 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $93,670 - $122,723	-2,533 Reduced 14.28%	15,201 $562,000
Q2 2019 Aug 15, 2019	BUY	$35.13 - $55.53 $622,995 - $984,769	17,734 New	17,734 $801,000
Q4 2018 Feb 15, 2019	SELL	$37.97 - $60.16 $925,404 - $1.47 Million	-24,372 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $1.05 Million - $1.25 Million	18,606 Added 322.68%	24,372 $1.48 Million
Q4 2017 Feb 15, 2018	SELL	$41.95 - $60.1 $496,981 - $712,004	-11,847 Reduced 67.26%	5,766 $273,000
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $588,274 - $949,340	17,613	17,613 $948,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.3M

Call Options Held

351K

Put Options Held

105K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $28.1M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Fibrogen Inc Transaction History